Ignite Creation Date:
2025-12-25 @ 12:41 AM
Ignite Modification Date:
2026-01-11 @ 3:05 PM
Study NCT ID:
NCT00826267
Status:
COMPLETED
Last Update Posted:
2013-12-31
First Post:
2009-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
6 Weeks Treatment of Locally Advanced Breast Cancer With BIBW 2992 (Afatinib) or Lapatinib or Trastuzumab
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-01
Start Date Type:
None
Primary Completion Date:
2011-08
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2009-01-20
First Submit QC Date:
None
Study First Post Date:
2009-01-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-08-08
Results First Submit QC Date:
None
Results First Post Date:
2013-10-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-12-05
Last Update Post Date:
2013-12-31
Last Update Post Date Type:
ESTIMATED